In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
Munshi
Anusheel
A
Jalali
Rakesh
R
Budrukar
Ashwini
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D018572:Disease-Free Survival; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant
D011838:Radiation-Sensitizing Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate